• RAPS' LatestRAPS' Latest

    How to be a Regulatory Leader

    Increasingly, regulatory professionals need to be effective leaders. Not only are they leading regulatory departments and cross-functional work groups, they also are being called upon to play key roles on corporate and organizational leadership teams. RAPS’ Scope of Practice Study shows that regulatory professionals now spend up to a third of their time working on strategy or business-related duties. Recognizing the value regulatory experts bring to the C-suite, s...
  • RAPS' LatestRAPS' Latest

    J&J’s Regulatory Executives Groomed as Business Leaders

    Over the past decade, life sciences companies have increasingly realized that regulatory expertise is a mission-critical business asset. The amount of time regulatory professionals spend on business and management-related duties has risen sharply at all job levels, according to RAPS’ own Scope of Practice & Compensation Study . Some, more forward-thinking companies are taking this a step further, actively grooming regulatory professionals to be business leaders and crea...
  • RAPS' LatestRAPS' Latest

    RAPS Fellows Share Experiences, Insight and Advice for the Next Generation

    When the Regulatory Affairs Professionals Society (RAPS) honored its 2012 class of RAPS Fellows last October during 2012 RAPS: The Regulatory Convergence in Seattle, the  12 newest Fellows joined an exclusive group of highly accomplished leaders. The  RAPS Fellows program recognizes senior regulatory professionals for their continued contributions, vision and dedication toward the advancement of the profession. Given that regulatory, as a profession, is rela...
  • RAPS' LatestRAPS' Latest

    Outstanding Contributions Deserve Outstanding Recognition

    Nominations are now open for RAPS awards, which go to regulatory professionals with diverse, global backgrounds. The RAPS Awards Committee is currently seeking nominations for RAPS' annual awards honoring outstanding regulatory professionals in the healthcare products sector. RAPS' awards programs provide an important opportunity to acknowledge outstanding individual contributors to the regulatory field. This year, the committee has made significant improvements to the...
  • AstraZeneca CEO Out as New J&J CEO Takes the Helm

    • 26 April 2012
    Two life sciences giants are experiencing transitions in leadership, as AstraZeneca's Chief Executive Office David Brennan announced he was relinquishing his position effective immediately and incoming Johnson & Johnson (J&J) CEO Alex Gorsky assumes his position at the company on 26 April. Rumors of Brennan's departure have been brewing for some time, but finally came to a head after the firm announced a 19% decrease in first-quarter profits, reports Reuters . T...
  • FDA Gets New COO

    Biocentury reports US Food and Drug Administration (FDA) Commissioner Margaret Hamburg has tapped Walter Harris, currently at the Centers for Disease Control and Prevention (CDC), to be FDA's new Chief Operating Officer (COO). At CDC, Harris served as both the Chief Human Capital and Resources Officer and the Deputy Director of the Office of Surveillance, Epidemiology and Laboratory Services (OSELS). Before arriving at CDC, Harris served as Acting Chief Information Off...